208 related articles for article (PubMed ID: 20153352)
1. Evaluation of Southern Hemisphere influenza vaccine recommendations.
Richard SA; Viboud C; Miller MA
Vaccine; 2010 Mar; 28(15):2693-9. PubMed ID: 20153352
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
3. Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2015.
Leung VK; Spirason N; Lau H; Buettner I; Leang SK; Chow MK
Commun Dis Intell Q Rep; 2017 Jun; 41(2):E150-E160. PubMed ID: 28899310
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 northern hemisphere season.
Barr IG; McCauley J; Cox N; Daniels R; Engelhardt OG; Fukuda K; Grohmann G; Hay A; Kelso A; Klimov A; Odagiri T; Smith D; Russell C; Tashiro M; Webby R; Wood J; Ye Z; Zhang W;
Vaccine; 2010 Feb; 28(5):1156-67. PubMed ID: 20004635
[TBL] [Abstract][Full Text] [Related]
5. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
Myers CA; Faix DJ; Blair PJ
Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
[No Abstract] [Full Text] [Related]
6. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
7. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y
J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166
[TBL] [Abstract][Full Text] [Related]
8. The genetic match between vaccine strains and circulating seasonal influenza A viruses in Vietnam, 2001-2009.
Vuong CD; Hoang PM; Nguyen HL; Nguyen HT; Nguyen TC; Le TT; Dennis DT; Kapella BK; Kile JC; Le MQ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1151-7. PubMed ID: 23137010
[TBL] [Abstract][Full Text] [Related]
9. Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2014.
Sullivan SG; Chow MK; Barr IG; Kelso A
Commun Dis Intell Q Rep; 2015 Dec; 39(4):E602-11. PubMed ID: 26779736
[TBL] [Abstract][Full Text] [Related]
10. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013.
Barr IG; Russell C; Besselaar TG; Cox NJ; Daniels RS; Donis R; Engelhardt OG; Grohmann G; Itamura S; Kelso A; McCauley J; Odagiri T; Schultz-Cherry S; Shu Y; Smith D; Tashiro M; Wang D; Webby R; Xu X; Ye Z; Zhang W;
Vaccine; 2014 Aug; 32(37):4713-25. PubMed ID: 24582632
[TBL] [Abstract][Full Text] [Related]
11. WHO recommendations on the composition of the 2013/14 influenza virus vaccines in the northern hemisphere.
Eurosurveillance editorial team
Euro Surveill; 2013 Feb; 18(9):. PubMed ID: 23470023
[No Abstract] [Full Text] [Related]
12. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011.
Kelly HA; Sullivan SG; Grant KA; Fielding JE
Influenza Other Respir Viruses; 2013 Sep; 7(5):729-37. PubMed ID: 23078073
[TBL] [Abstract][Full Text] [Related]
13. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
14. Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe.
Broberg E; Melidou A; Prosenc K; Bragstad K; Hungnes O;
Euro Surveill; 2016; 21(13):. PubMed ID: 27074657
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season.
Sullivan SG; Arriola CS; Bocacao J; Burgos P; Bustos P; Carville KS; Cheng AC; Chilver MB; Cohen C; Deng YM; El Omeiri N; Fasce RA; Hellferscee O; Huang QS; Gonzalez C; Jelley L; Leung VK; Lopez L; McAnerney JM; McNeill A; Olivares MF; Peck H; Sotomayor V; Tempia S; Vergara N; von Gottberg A; Walaza S; Wood T
Euro Surveill; 2019 Nov; 24(45):. PubMed ID: 31718744
[TBL] [Abstract][Full Text] [Related]
16. Using surveillance to evaluate influenza vaccine effectiveness.
Jackson LA
J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
[No Abstract] [Full Text] [Related]
17. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
[TBL] [Abstract][Full Text] [Related]
18. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
[TBL] [Abstract][Full Text] [Related]
19. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
King JC; Lichenstein R; Magder LS
Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
